Effect of halothane on lung carcinoma cells A 549

Chemico-Biological Interactions

Volumn 146, Issue 2, 2003, Pages 191-200

  Valtcheva, Ralitza ^a   Stephanova, Elena ^a   Jordanova, Albena ^b   Pankov, Roumen ^c   Altankov, George ^b   Lalchev, Zdravko ^a  

^a UNIVERSITY OF SOFIA   (Bulgaria)

^b INSTITUTE OF BIOPHYSICS AND BIOMEDICAL ENGINEERING   (Bulgaria)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

A 549; Cytotoxicity; Halothane; Pulmonary surfactant

Indexed keywords

HALOTHANE; LACTATE DEHYDROGENASE;

AQUEOUS SOLUTION; ARTICLE; CARCINOMA CELL; CELL ADHESION; CELL METABOLISM; CELL POPULATION; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; LUNG CARCINOMA; SURFACE TENSION;

MYCOBACTERIUM AVIUM COMPLEX (MAC);

EID: 0142155720     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2003.08.002     Document Type: Article

References (51)

1. Tonnesen E. Immunological aspects of anaesthesia and surgery. Dan. Med. Bull. 36:1989;263-281.
2. Salo M. Effects of anaesthesia and surgery on the immune response. Acta Anasthesiol. Scand. 36:1992;201-220.
3. Pollock R.E., Lotzova E., Stanford S.D. Surgical stress impairs natural killer cell programming of tumor for lysis in patients with sarcomas and other solid tumors. Cancer. 70:1992;2192-2202.
4. Ben-Elyahu S., Page G.G., Yirmiya R., Shakhar G. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int. J. Cancer. 80:1999;880-888.
5. Bar-Yosef S., Melamed R., Page G.G., Shakhar G., Shakhar K., Ben-Eliyahu S. Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats. Anesthesiology. 94:2001;1066-1073.
6. O'Keffee N., Healy T. The role of new anesthetic agents. Pharmacol. Therapeut. 84:1999;233-248.
7. Bourdi M., Amouzdeh H., Rushmore T., Martin J., Pohl L. Halothane-induced liver injury in outbred guinea pigs: role of trifluoracetylated protein adducts in animal susceptibility. Chem. Res. Toxicol. 14:2001;362-370.
8. Pohl L., Kenna J., Satoh H., Christ D., Martin J. Neoantigens associated with halothane hepatitis. Drug Metab. Rev. 20:1989;203-217.
9. Hoet P., Graf M.-L., Bourdi M., Pohl L., Duray P., Chen W., Peter R., Nelson S., Verlinden N., Lison D. Epidemic of liver disease caused by hydrochlorofluorocarbons used as ozone-sparing substitutes of chlorofluorocarbons. Lancet. 350:1997;556-559.
10. Hoet P., Buchet J., Sempoux C., Nomiyama T., Jacques R., Lison D. Investigations on the liver toxicity of a blend of HCFC-123 (2,2-dichloro-1,1,1- trifluoroethane) and HCFC-124 (2-chloro-1,1,1,2-tetrafluoroethane) in guinea-pigs. Arch Toxicol. 75:2001;274-283.
11. Harris J., Pohl L., Martin J., Anders M. Tissue acylation by the chlorofluorocarbon substitute 2q2-dichloro-1,1,1-thrifluoroethane. Proc. Natl. Acad. Sci. U.S.A. 88:1991;1407-1410.
12. Harris J., Johnes J., Martin J., La Rosa A., Oison M., Pohl L., Anders M.W. Pentahaloethane-based chlorofluorocarbon substitutes and halothane: correlation of in vivo hepatic protein trifluoroacetylation and urinary trifluoroacetic acid excretion with calculated enthalpies of activation. Chem. Res. Toxicol. 5:1992;720-725.
13. Kenna J., Satoh H., Christ D., Pohl L. Metabolic basis for drug hypersensitivity: antibodies in sera from patients with halothane recognize liver neoantigens that contain the trifluoracetyl group derived from halothane. J. Pharmacol. Exp. Ther. 245:1988;1103-1109.
14. Kitteringham N., Kenna J., Park B. Detection of autoantibodies directed against human hepatic endoplasmic reticulum in sera from patients with halothane-associated hepatitis. Br. J. Clin. Pharmacol. 40:1995;379-386.
15. Lunam C., Hall P., Cousins M. The pathology of halothane hepatotoxicity in a guinea-pig model: a comparison with human halothane hepatitis. Br. J. Exp. Pathol. 70:1989;533-541.
16. Pascon E., Spangberg L. In vitro cytotoxicity of root canal filling materials. 1. Gutta-percha. J. Endoodon. 16:1990;429-433.
17. Barbosa S., Burkard D., Spangberg L. Cytotoxic effects of gutapercha solvents. J. Endoodon. 20:1994;6-8.
18. Olsson B., Sliwkowski A., Langeland K. Intra-osseous implantation for biological evaluation of endoodontic materials. J. Endoodon. 7:1981;253-265.
19. Olsson B., Wennberg A. Early tissues reaction to endodontic filling materials. Endod. Dent. Traumatol. 1:1985;138-141.
20. Chang Y., Chou M. Cytotoxicity of halothane on human gingivial fibroblast cultures in vitro. J. Endod. 27:2001;82-84.
21. Itoh T., Namba T., Fukuda K., Semenza G., Hirota K. Reversible inhibition of hypoxia-inducible factor 1 activation by exposure of hypoxic cells to the volatile anesthetic halothane. FEBS Lett. 509:2001;225-229.
22. Semenza G. HIF-1 and human disease: one highly involved factor. Genes Dev. 14:2000;1983-1991.
23. Lalchev Z., Christova Y., Todorov R., Alexandrov V., Stoichev P., Petkov R. Alterations of biochemical and physicochemical quantities of pulmonary lavages attending halothane and penthrane treatment in rats. Appl. Cardiopul. Pathophysiol. 4:1992;315-322.
24. Tobin R., Kaiser H., Groeger A., Lema M. The effects of volatile anesthetic agents on pulmonary surfactant function. In vivo. 14:2000;157-164.
25. Johnson S., Bangham A. The action of anesthetics on phospholipid membranes. Biochim. Biophys Acta. 193:1969;92-104.
26. Dzoljic M., Bene L., Krasznai Z., Damjanovich S., Van Duijn B. Ethanol and halothane differently modulate the HLA class I and class II oligomerization. A new look at the mode of action of anesthetic agents through fluorescence spectroscopy. J. Photochem. Photobiol. B. 56:2000;48-52.
27. Franks N., Lieb W. Molecular and cellular mechanisms of general anesthesia. Nature. 333:1994;662-664.
28. + channel. EMBO J. 15:1998;6854-6862.
29. Ries C., Puil E. Ionic mechanism of isoflurane's actions on thalamocortical neurons. J. Neurophysiol. 81:1999;1802-1809.
30. Sirois J., Pancracio J., Lynch C. III, Bayliss D. Multiple ionic mechanisms mediate inhibition of rat motoneurones by inhalation anaesthetics. J. Physiol. (Lond.). 512:1998;851-862.
31. Sirois J., Lei Q., Talley E., Lynch C. III, Bayliss D. The TASK-1 two-pore domain K+ channel is a molecular substrate for neuronal effects of inhalation anesthetics. J. Neurosci. 20:2000;6347-6354.
32. Wineger B., Owen D., Yost C., Forsayeth J., Mayeri E. Volatile general anesthetics produce hyperpolarization of aplysia neurons by activation of discrete population of baseline potasium Channels. Anesthesiology. 85:1996;889-900.
33. Nicoll R., Madisson D. General anesthetics hiperpolaryze neurons in the vertebrate central nervous system. Science. 217:1982;1055-1057.
34. Kudoh A., Matsuki A. Sevoflurane stimulates inositol 1,4,5-trisphosphate in skeletal muscle. Anesth Analg. 91:2000;440-445.
35. 2+ homeostasis. Ital. J. Neurol. Sci. 20:1999;431-435.
36. He D., Burt J. Mechanism and selectivity of the effects of halothane on gap junction channel function. Circ. Res. 86:2000;E104-E109.
37. Batai I., Kerenyi M. Halothane decreases bacterial adherence in vitro. Acta Anaesthesiol. Scand. 43:1999;760-763.
38. Z. Lalchev, Surface properties of lipids and proteins at bio-interfaces, in: K. Birdi (Ed.), Handbook of Surface and Colloid Chemistry. CRC Press, Boca Raton, New York, 1997, pp. 625-687.
39. R. Sanders, The composition of pulmonary surfactant, in: P. Farrel (Ed.), Lung Development: Biological and Clinical Perspectives, vol. 1, Academic Press, New York, 1982.
40. Molliex S., Crestani B., Dureuil B., Bastin J., Rolland C., Aubier M., Desmonts J. Effects of halothane on surfactant biosynthesis by rat alveolar type II cells in primary culture. Anesthesiology. 81:1994;668-676.
41. Paugam-Burtz C., Molliex S., Lardeux B., Rolland C., Aubier M., Desmonts J., Crestani B. Differential effects of halothane and thiopental on surfactant protein C messenger RNA in vivo and in vitro in rats. Anaesthesiology. 93:2000;805-810.
42. Lieber M., Smith B., Szakal A., Nelson-Rees W., Rodaro G. A continuous tumor-cell line from a human lung carcionma with properties of type II alveolar epithelial cells. Int. J. Cancer. 17:1976;62-70.
43. Franks N., Lieb W. Temperature dependence of potency of volatile general anaesthetics implications for in vitro experiments. Anaesthesiology. 84:1996;716-720.
44. Bligh E., Dyer W. A rapid method of total lipid extraction and purification. Can. J. Biochem. 37:1959;911.
45. Kahovkova J., Odavic R. A simple method for analysis of phospholipids separated on thin layer chromatography. J. Chromat. 40:1969;143-152.
46. Hynes R. Integrins: versatility. Cell. 69:1992;11-25.
47. Frisch S., Ruoslahti E. Integrins and anoikis. Curr. Opin. Cell Biol. 9:1997;701-706.
48. Bazil C., Raux M., Yudell S., Minneman K. Equilibration of halothane with brain tissue in vitro:comparison to concentration during anaesthesia. J. Neurochem. 49:1987;952-958.
49. Watamane N., Dickinson D., Krzywanski D., Iles K., Zhang H., Venglarik C., Forman H. A 549 subclones demonstrate heterogeneity in toxicological sensitivity and antioxidant profile. Am. J. Physiol. Lung Cell Mol. Physiol. 283:2002;L726-L736.
50. J.S. Lwebuga-Mukasa, Isolation of type II alveolar epithelial cells, in: S. Uhlig, A.E. Taylor (Eds.), Methods in Pulmonary Research, Birkhauser Verlag, Basel, 1998, pp. 387-400.
51. Spragg R.G., Li J. Effect of Cytidylyltransferase overexpression on phosphatidylcholine synthesis in alveolar type II cells and related cell lines. Am. J. Respir. Cell Mol. Biol. 22:2000;116-124.